Table 2 Adherence of healthcare providers to national malaria guidelines, Oct 2016—Jan 2017
Characteristics | PPM facilities | Non-PPM facilities | Chi-square | P-value | ||
|---|---|---|---|---|---|---|
Frequency | % | Frequency | % | |||
Diagnosis methods | ||||||
 Microscopy n1 = 1330 | 150 | 83% | 72 | 48% | 45.74 | 0.001 |
 Multi-species RDTs n2 = 320 | 16 | 9% | 36 | 24% | ||
 Presumed malaria n3 = 1,376 | 14 | 8% | 42 | 28% | ||
Parasitological confirmed malaria | Â | Â | Â | Â | Â | |
 P. falciparum | 92 | 51.1% | 52 | 46.8% | 1.45 | 0.483 |
 P. vivax | 46 | 25.6% | 36 | 32.4% | ||
 Mixed (P. f or both P. f and P. v) | 28 | 15.6% | 20 | 18.0% | ||
Treatments adhered to guidelines | ||||||
P. falciparum, mixed (P. f or both P. f and P. v) & presumed malaria | ||||||
 AL plus primaquine (sld) | 0 | 0.00% | 0 | 0.00% | NA | NA |
 Quinine plus primaquine (sld) | 0 | 0.00% | 0 | 0.00% | ||
P. vivax | ||||||
 Chloroquine | 39 | 84.8% | 29 | 80.56% | 0.255 | 0.614 |
Treatments not adhered to guidelines | ||||||
P. falciparum | ||||||
 AL or quinine | 82 | 89.1% | 12 | 23.1% | 83.31 | 0.001 |
 AL plus artemether injection and antibiotics | 7 | 7.6% | 0 | 0.0% | ||
 Artemether injection | 3 | 3.3% | 40 | 76.9% | ||
Mixed (P.f or both P. f and P. v) | ||||||
 AL or quinine | 10 | 35.7% | 2 | 10.0% | 14.1 | 0.001 |
 AL plus artemether injection and antibiotics | 18 | 64.3% | 8 | 40.0% | ||
 Artemether injection | 0 | 0.0% | 10 | 50.0% | ||
P. vivax | ||||||
 AL or chloroquine plus primaquine | 3 | 6.5% | 0 | 0.0% |  | *1.000 |
 Chloroquine plus artemether injection and antibiotics | 2 | 4.3% | 4 | 11.1% | ||
 Artemether injection | 2 | 4.3% | 3 | 8.3% | ||
Presumed malaria | ||||||
 AL or quinine | 4 | 28.6% | 18 | 42.9% |  | *0.756 |
 Artemether injection and antibiotics | 1 | 7.1% | 1 | 2.4% | ||
 Chloroquine | 9 | 64.3% | 23 | 54.8% | ||